Page last updated: 2024-12-05

phosphorus sesquisulfide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID14818
MeSH IDM0104561

Synonyms (26)

Synonym
phosphorus sesquisulfide, free from yellow or white phosphorous
sesquisulfure de phosphore
phosphorus sesquisulfide, free from yellow or white phosphorous [un1341] [flammable solid]
unii-8v5q0m194y
8v5q0m194y ,
hsdb 1257
trisulfurated phosphorus
sesquisulfure de phosphore [french]
phosphorus sulfide (p4s3)
3,5,7-trithia-1,2,4,6-tetraphosphatricyclo(2.2.1.02,6)heptane
phosphorous sesquisulfide
phosphorus (iii) sulfide (iv)
einecs 215-245-0
phosphorus(iii) sulfide(iv)
ai3-15014
un1341
phosphorus sesquisulfide
tetraphosphorus trisulfide
1314-85-8
3,5,7-trithia-1,2,4,6-tetraphosphatricyclo[2.2.1.02,6]heptane
un-1341
tetraphosphorus trisulfide [mi]
phosphorus sesquisulfide [hsdb]
DTXSID4074562
p4s3
Q2454591
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (57.14)18.7374
1990's2 (14.29)18.2507
2000's3 (21.43)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.52 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index42.51 (26.88)
Search Engine Supply Index2.07 (0.95)

This Compound (33.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.14%)5.53%
Reviews0 (0.00%)6.00%
Case Studies8 (57.14%)4.05%
Observational0 (0.00%)0.25%
Other5 (35.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]